Literature DB >> 1973700

Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).

A Steinmetz1, N Assefbarkhi, C Eltze, K Ehlenz, H Funke, A Pies, G Assmann, H Kaffarnik.   

Abstract

A family with three heterozygote and two homozygote carriers of the rare apolipoprotein E1 isoform was detected by isoelectric focusing. One of the homozygous patients had type III hyperlipidemia, while the other showed normolipemic dysbetalipoproteinemia. Restriction fragment length analysis as well as allele specific oligonucleotides were used to identify the structural alterations forming the abnormal epsilon 1 genotype. Comparison with the most common epsilon 3 allele showed that two base exchanges A for G in codon 127 and T for G in codon 158 (Asp for Gly and Cys for Arg, respectively) are responsible for the amino acid substitution which causes the charge shift observed in isoelectric focusing. The same defects have been described in the only previously characterized apoE1 (Weisgraber et al. 1984. J. Clin. Invest. 73: 1024-1033). In addition to the study by Weisgraber and coworkers, who reported on a heterozygous patient, we here describe the metabolic and clinical consequences of a homozygosity for this rare allele. Changes in lipoprotein metabolism, as well as in clinical phenotypes, were exactly identical to those seen in patients homozygous for the epsilon 2 allele, which has in common with the epsilon 1 allele the mutation in codon 158, but lacks the substitution in codon 127. In addition, lipoprotein profiles of the epsilon 3/epsilon 1 heterozygotes were indistinguishable from those of epsilon 3/epsilon 2 heterozygotes. Therefore, we conclude that the additional mutation in codon 127 that characterizes the epsilon 1 allele is of no functional importance in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973700

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  The fourth apolipoprotein E haplotype found in the Yoruba of Ibadan.

Authors:  Jill R Murrell; Brandon M Price; Olusegun Baiyewu; Oye Gureje; Mark Deeg; Hugh Hendrie; Adesola Ogunniyi; Kathleen Hall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

2.  APOE ε4 allele modifies the association of lead exposure with age-related cognitive decline in older individuals.

Authors:  Diddier Prada; Elena Colicino; Melinda C Power; Marc G Weisskopf; Jia Zhong; Lifang Hou; Avron Spiro; Pantel Vokonas; Kasey Brenan; Luis A Herrera; Joel Schwartz; Robert Wright; Howard Hu; Andrea A Baccarelli
Journal:  Environ Res       Date:  2016-07-27       Impact factor: 6.498

3.  Genotyping of a patient homozygous for a rare apolipoprotein E1 [Gly127-->Asp; Arg158-->Cys] (Weisgraber allele).

Authors:  A Iron; P Richard; M P de Zulueta; G Thomas; M Thomas
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.

Authors:  G Feussner; R Ziegler
Journal:  Clin Investig       Date:  1992-07

5.  Severe Combined Dyslipidemia With a Complex Genetic Basis.

Authors:  Ryan Le; Minan Abbas; Adam D McIntyre; Robert A Hegele
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.